Active Ingredient History

  • Now
Beloranib is a former drug candidate for the treatment of obesity. It was discovered by CKD Pharmaceuticals and its clinical development was led by Zafgen. Drug development was halted in 2016 after deaths during clinical trials.   Wikipedia

More Chemistry
beloranib | ckd732 | ckd-732 | o-(4-dimethylaminoethoxycinnamoyl)fumagillol


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue